The New England Society for Vascular Surgery: 25 years and counting  by Cronenwett, Jack L.
In the summer of 1973 I had just finished med-
ical school at Stanford and moved to Michigan to
begin surgical residency. That same summer, nearly
1000 miles to the east, three senior surgeons in
Boston, Drs Robert R. Linton, R. Clement Darling
Jr, and Ralph A. Deterling Jr, were discussing the
future of vascular surgery in New England (Figs 1,
2, and 3). At that time, vascular surgery was well
established in their practices, as it was in other large
centers. The Society for Vascular Surgery had
already been meeting for 25 years. However, rela-
tively few surgeons in rural New England were pre-
pared to perform major vascular procedures. Thus
crusty old New Englanders with vascular disease had
to be transferred long distances for surgery, which
was about as popular then as it is today. Accordingly,
Linton, Darling, and Deterling conceived the idea of
a regional vascular society to promote this discipline
among surgeons in New England. They were opti-
mistic that such a focused effort would be successful
in the relatively small geographic region of the six
New England states. Their principal goal was to hold
annual meetings of the society for the education of
its members to discuss common vascular problems.
They also recognized a need to develop postgradu-
ate training in vascular surgery, advise third party
payers, and assist with peer review in this developing
specialty. Apparently, even by 1973 the national vas-
cular societies were perceived as being too large or
remote to meet these needs at a regional level. As a
result of their foresight, we are here 25 years later as
the proud custodians of the oldest regional vascular
surgery society. In fact, the New England Society for
Vascular Surgery (NESVS) was to serve as a proto-
type for other regional vascular societies; the
Midwestern and Southern societies were founded in
1976; and the Eastern and Western societies were
founded in 1986.
Humankind has always been fascinated with the
passage of time, no doubt because of our own mor-
tality. We commemorate birthdays and anniversaries
with great celebration, to mark the success of
another year of business, of marriage, or simply of
living. We attach special significance to anniversaries
that occur every quarter of a century because most
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Fig 1. Robert R. Linton, MD, First President, New
England Society for Vascular Surgery.
of us live to see, or remember, only one or two of
these. So it is appropriate, or at least traditional, for
us to reflect today on the 25 successful years that we
commemorate on this silver anniversary of our
Society. I was tempted to devote this address to the
history of our Society, but fortunately for all of us,
Dr Nathan Couch, our enlightened Archivist,
stepped up to this task brilliantly, as you heard last
night. Having been relieved of this monumental
effort, I thought that my task for today should be
to focus our attention on the next 25 years, to be
sure that our Society counts as much for its mem-
bers then as it does today. Unfortunately, we are
now living in an era when future planning does not
require a calendar, but rather a stopwatch. Thus I
am afraid that even if my predictions or suggestions
are valid today, they will be questionable tomorrow,
and certainly ephemeral in 25 years. However, as I
reflect on the 24 presidents and other officers who
have preceded me and as I survey the talent in this
audience, I realize that it will not matter. New chal-
lenges will be met by leaders more capable than I;
progress will occur; and our Society will continue to
meet the demands of vascular surgeons in this
region, as conceived by its founders. Thus although
I could retire with the shortest presidential address
in history, I beg your indulgence to hear a few of
my concerns and suggestions as we embark on our
next 25 years.
The questions that I posed in preparation for this
address were simply, “How well do we meet the
needs of our members and how could we improve?”
I did not perform a scientific survey to answer these
questions, but during my tenure as Secretary and
President, I have enjoyed the opportunity to discuss
these issues with many of you. One way to judge the
perceived value of any group is simply by the growth
of its membership. By that standard, our Society has
grown impressively, by nearly 10% per year, from 17
members at its inception to 238 members today; this
is undoubtedly a reflection of continuing success in
meeting the needs of the membership. For most
members, our Society is synonymous with its annual
meeting, where continuing education is addressed
largely through scientific presentations. These pre-
sentations provide a stimulus for discussion of 
common vascular problems, as envisioned by our
founders. In contrast to the national vascular meet-
ings, the small size of our meeting and the lack of
invited soliloquies allow full membership participa-
tion. This advantage has always been highlighted
during our Case Discussion Panel and more recently
in the breakfast meeting of interesting case presenta-
tions. The Issues Committee, descended from the
original Professional Activities Committee, has stim-
ulated important socioeconomic discussions among
our membership. The Deterling award and now the
Darling award have been instituted to stimulate
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Fig 2. Ralph A. Deterling, Jr, MD, Second President,
New England Society for Vascular Surgery.
Fig 3. R. Clement Darling, Jr, MD, First Secretary-
Treasurer and Eighth President, New England Society for
Vascular Surgery.
research by vascular trainees. The Linton Lecture and
our Distinguished Address have provided stimulation
from visiting experts in the field. Thus it would
appear that our Society meets its objectives (as out-
lined in our Constitution), namely, encouraging
postgraduate education, holding regular scientific
meetings, and improving the treatment of patients
with vascular disease.
However, before we become too satisfied with
our success, let us take a lesson from continuous
quality improvement and look at the needs of our
principal “customers,” the vascular surgeons in
New England. Despite our common interest, we
are a heterogeneous group with differences in aca-
demic versus private practice, large versus small
communities, and the percentage of our practice
that we devote to vascular surgery, to name a few.
In a completely biased and nonscientific survey,
however, I have learned that the major current
needs of our members are quite similar: first, a
need for adequate financial reimbursement for vas-
cular procedures; second, a need for instruction in
evolving vascular technologies; and third, a need
for protected time for academic endeavors. Let us
look at each of these to see whether our Society
could have a beneficial role.
REIMBURSEMENT FOR VASCULAR 
PROCEDURES
When I moved to Dartmouth 14 years ago, it was
relatively easy to make a good living as a vascular sur-
geon. Protected time for research was relatively plen-
tiful, financed by the profits of a successful clinical
practice. I do not need to tell anyone in this audience
that times have changed. I have been fortunate dur-
ing the past 10 years to work with Bob Zwolak, who
is one of the experts in Medicare reimbursement in
this country. In fact, today Bob is at a meeting of the
Relative Value Update Committee, where he has been
quite successful in working on our behalf.
Unfortunately, as I have learned from Bob, we have a
long way to go. Vascular surgeons care for the largest
percentage of Medicare patients of any subspecialty in
this country. You might say, “well, Medicare reim-
bursement isn’t lower than most managed care con-
tracts.” But that is not the only issue. Through a vari-
ety of quirks in the development of the relative value
scale, work by vascular surgeons is substantially under-
valued compared with other surgical specialties.
Consider the variation in relative value units (RVUs)
per hour of “skin-to-skin” operative time for common
surgical procedures in different specialties (Fig 4). As
you know, RVUs are used by Medicare to determine
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 6 Cronenwett 951
Fig 4. Operative work (RVUs per hour) based on intraservice physician work intensity and
average “skin-to-skin” operative times for common procedures by different specialists, based
on 1998 Medicare resource-based relative value scale schedules.
physician reimbursement. Operative work per hour is
calculated from the RVUs assigned to the operative
(intraservice) component of a procedure divided by
the average duration of that procedure. As shown in
Fig 4, a urologist performing a transurethral prostatic
resection accumulates operative RVUs at a rate nearly
four times faster than a vascular surgeon performing a
femoral popliteal vein graft. Simply stated, a urologist
doing a transurethral prostatectomy is reimbursed at
an hourly rate that is nearly four times higher than a
vascular surgeon doing a femoropopliteal vein graft.
Vascular surgery procedures are generally underval-
ued compared with common operative procedures in
other specialties, although common general surgery
procedures are in the middle of this range (Fig 4). In
other words, we are not playing on a level playing
field.1 It is also instructive to compare reimbursement
for vascular reconstructions with comparable percuta-
neous treatment of the same lesions. As an example,
consider a patient with claudication from unilateral
iliac occlusive disease who is a candidate for either
femoral-femoral bypass, iliofemoral bypass or percuta-
neous dilation, and stenting of the common and
external iliac artery. Medicare reimbursement for the
percutaneous procedures includes not only the “sur-
gical” CPT codes for the actual procedures, but the
traditional radiology “supervision and interpretation”
codes (Table I). The total work for percutaneous
angioplasty and stent placement in the common 
and external iliac arteries, not including the associated
angiography, is 45.54 RVUs, for an allowable 
1998 Medicare reimbursement of $1589 (without 
geographic modification). Compare this with total 
RVUs of 30.98 and 35.91 for femoral-femoral and
iliofemoral bypass, for a total allowable Medicare
physician reimbursement of $1096 and $1271 (Table
I). Furthermore, note that payment for the vascular
surgery procedures includes care during the subse-
quent 90-day global period, although postprocedure
care after the percutaneous procedures would be
reimbursed separately. In short, it appears that most
other surgical specialists, as well as interventional radi-
ologists, are being reimbursed at a substantially high-
er rate per unit of time or comparable procedure than
vascular surgeons. These issues are being addressed on
a national level by skilled members of our societies,
but we do have a long way to go. 
Is there anything that our Society can do on a
regional level to affect reimbursement for vascular sur-
geons? As most of you know, Medicare reimbursement
is distributed through regional medical carriers that
have responsibility for decision-making and policy
interpretation within their region. In New England,
there is one carrier for New Hampshire, Vermont,
Maine, and Massachusetts, with separate carriers for
Connecticut and Rhode Island. To facilitate decision-
making concerning reimbursement for new proce-
dures and other controversial issues, each Medicare
carrier uses a Carrier Advisory Committee that in-
cludes physicians from different specialties. Two of the
three Medicare carriers in New England have vascular
surgery representation, from four of the six New
England states. In recent years, questions concerning
reimbursement of endovascular aneurysm repair and
duplex scanning after carotid endarterectomy are
among the issues that have been considered by
Medicare carriers. It would seem eminently logical that
our regional vascular society should provide organized
input to these carriers concerning such decisions.
Effective communication between professional soci-
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Table I. Medicare 1998 reimbursement
RVUs
Allowable Global time
Procedure CPT code MD Work Total charge* covered (days)
Femoral-femoral prosthetic bypass 35661 13.18 30.98 $1,096 90
Iliofemoral prosthetic bypass 35665 15.4 35.91 $1,271 90
Iliac angioplasty and stent placement
Common iliac angioplasty 35473 6.04 14.21 $503 0
Supervision and intervention 75962 0.54 0.83 $29
Common iliac stent 37205 8.28 13.86 $483 0
Supervision and intervention 75960 0.82 1.25 $43
External iliac angioplasty† 35473 3.02 7.1 $251 0
Supervision and intervention 75962 0.54 0.83 $29
External iliac stent 37206 4.13 6.92 $483 0
Supervision and intervention 75964 0.36 0.54 $19
TOTAL: percutaneous procedure 23.73 45.54 $1,589 0
*Unadjusted for geographic region.
†Second angioplasty valued at 50% (multiprocedure rule).
eties and Medicare carriers would seem to be of obvi-
ous mutual benefit and might lead to long-term coop-
eration and even focused research to address the cost-
benefit of questionable practices. This could aid the
carriers, vascular surgeons, and ultimately our mutual
patients. Such activity could logically be extended to
all third-party payers. Accordingly, I would propose
that our Society establish a Payer Liaison Committee
to contact and communicate with Medicare carriers
and other third party payers and managed-care organi-
zations in the New England region. Members of our
Society who are currently on the various Carrier
Advisory Committees would be logical initial mem-
bers of this group. This would allow a more coordi-
nated effort to address reimbursement issues concern-
ing vascular procedures. As the representative of vas-
cular surgeons in New England, our Society does not
seem to have sufficiently discharged this obligation to
its members.
CONTINUING EDUCATION IN NEW
TECHNOLOGIES
I doubt that our distinguished speaker of last
year, Dr Juan Parodi, had any idea of the fury that
he was unleashing in 1991 when he first treated an
aortic aneurysm using an endoluminal graft.2 For
many vascular surgeons who were “just busy taking
care of patients,” this was a wake-up call. It was
accompanied by the near replacement of renal artery
reconstruction by balloon angioplasty and stenting,
and the concern that even carotid artery disease
might be treated percutaneously. Historically, vascu-
lar surgeons have managed patients with peripheral
vascular disease largely in isolation, without the par-
ticipation of internal medicine counterparts. This
has changed in recent years in some centers, where
vascular medicine specialists, cardiologists, or radiol-
ogists have collaborated with vascular surgeons,
often forming vascular centers for better overall
patient care. Most vascular surgeons, however, con-
tinue to initially evaluate patients, make diagnoses,
recommend treatment, perform procedures, and
undertake long-term follow-up care. Traditionally,
vascular surgeons have referred patients to radiolo-
gists for diagnostic angiography and, when appro-
priate, for percutaneous endovascular procedures.
The benefit of this collaboration has been that expe-
rienced vascular surgeons contributed to the deci-
sion-making and that radiologists had the catheter-
based skills necessary for the percutaneous proce-
dures. In recent years, however, two developments
have dramatically changed this interaction. First,
advances in endovascular techniques have greatly
expanded the potential applications for percuta-
neous treatment. Second, radiologists and cardiolo-
gists have successfully received direct referrals, often
eliminating input from a vascular surgeon. This has
led to our current state of affairs, where vascular sur-
geons with the most knowledge and experience in
the treatment of vascular disease find themselves
threatened with exclusion from this process because
of a lack of experience with percutaneous, catheter-
based procedures. In a few centers, this has led to an
effective union of vascular surgery and intervention-
al radiology groups, but in most places, fierce com-
petition has developed. In either case, whether col-
laboratively or independently, most vascular sur-
geons have concluded that our specialty must
embrace catheter based-techniques and now seek
appropriate training in that regard. The proliferation
of institutional-sponsored training programs con-
cerning endovascular procedures is testimony to this
perceived need. 
Is there anything that our Society should do to
meet the needs of its members for continuing educa-
tion in this regard? I believe that there is. Although
the format of our annual meeting has encouraged a
discussion of the latest developments in vascular
surgery, it has not devoted time to continuing edu-
cation in specific areas, as is done in most continuing
medical education (CME) courses. Obviously, the
choice of topics for continuing education should be
driven by the specific needs of our members. This
could be assessed each year as part of our meeting
evaluation form, to allow adequate preparation for
the next annual meeting. 
In considering the possible content for continuing
education, perhaps we should take a lesson from the
annual meetings of our colleagues in other specialties.
For example, during the 1998 meeting of the Society
for Cardiovascular and Interventional Radiology, 42
separate workshops were conducted to teach specific
techniques.3 Among the topics were carotid stenting
and appropriate coding and billing for procedures. In
addition to these workshops, a number of categoric
CME courses were conducted by the radiologists,
including one entitled “Surgical Principles,” in which
the specific topics were principles of wound healing,
principles of sterile technique, incision closure tech-
niques, and surgical management of wound infections.
Do these topics give you the sense that radiologic 
societies are better preparing their members for the
future than vascular surgical societies? If not, consider 
a featured symposium at the 1998 Society for
Cardiovascular and Interventional Radiology meeting
entitled, “Credentialing Strategies to Protect Your
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Interventional Department.” The learning objectives
for this symposium were “(1) distinguish turf issues
based on economics vs quality; (2) list five responses to
turf battles; and (3) list three quality indicators for per-
cutaneous stent placement that may be useful in turf
issues.”3 This session provided a detailed list of talking
points and strategies to prevent vascular surgeons from
obtaining credentialing to perform endovascular pro-
cedures. Although the focus of our annual meeting
should continue to be the scientific advancement of
our discipline, these educational efforts by our col-
leagues or competitors remind us that our perspective
should not be narrow. Topics like appropriate coding
and billing for procedures and performance of
catheter-based techniques are just two opportunities
for our Society to benefit its members in a more
broad-based definition of continuing education.
It is impossible within the current time frame-
work of our annual meeting to include a substantial
new session on continuing education without elimi-
nating a desirable portion of the program. Thus I
would suggest that our meeting be expanded by one
half to one day per year to accommodate a continu-
ing education session, with its initial focus to be the
education of our members in catheter-based tech-
nology. Although such techniques are being prac-
ticed by vascular surgeons in selected centers in New
England, they have not been disseminated into most
practices. This is strikingly analogous to the situation
in 1973 when Linton, Darling, and Deterling per-
ceived the need to spread the knowledge of major
vascular surgery throughout our region. I believe
that it is time for our Society to take this same ini-
tiative with respect to endovascular training and
other current needs of our membership.
COOPERATIVE CLINICAL RESEARCH
Finally, let me turn my attention to an insidious
problem that I believe will have a potentially grave
impact on vascular surgery over the next 25 years.
That problem is our diminishing ability to perform
effective clinical research. Much has been written
about declining time for research by university faculty
because of increased clinical demands to meet the
bottom line in a time of relative financial hardship.
Not only has practice-derived internal funding and
government-derived external funding been reduced,
but third-party payers no longer reimburse the cost of
“extra” tests that were once the backbone of clinical
research. For most of us involved with clinical
research, however, the biggest problem is a lack of
time to devote to academic activity. I keep looking for
a “day-stretcher,” but all I have found is a “night-
shrinker.” This is also true in private practice, where
clinical demands are expanding and once commonly
published reviews of large clinical experience are
rapidly decreasing. Concern about reduced clinical
research is a focus of national attention. This is well
summarized in a 1997 review by Drs Thompson and
Moskowitz4 of Bowman Gray University entitled,
“Preventing the Extinction of the Clinical Research
Ecosystem.” In their commentary in the Journal of
the American Medical Association, these authors call
for a national reinvestment in the training of physi-
cian-investigators, which they believe is the key for
effective clinical research. In the same issue, Dr
Kenneth Shine5 of the National Academy of Sciences
highlights the massive reduction in practice-derived
funding for clinical research and points out the imper-
ative to replace this funding by both public and pri-
vate agencies. Both of these solutions focus on the
large national investment needed for multicenter ran-
domized controlled trials that are the pinnacle of clin-
ical scientific inquiry. This type of study has certainly
benefitted patients with vascular disease, as exempli-
fied by the North American Symptomatic Carotid
Endarterectomy Trial and Asymptomatic Carotid
Atherosclerotic Study. However, such studies are
notoriously difficult to organize and fund, which has
led to their infrequent performance. Nevertheless,
vascular surgery has matured tremendously because of
outstanding clinical research during the past 25 years,
including the works presented at our annual meet-
ings. Often these reports have documented the suc-
cess of specific techniques and procedures by retro-
spective comparison within a large group of patients.
Usually, these have not been randomized trials but
have still had substantial scientific merit. Randomized
trials have been performed in single institutions but
are often limited by inadequate patient numbers.
Thus although most would conclude that the solution
to diminishing clinical research requires a massive
national effort, in the New Hampshire spirit of less
government, I would ask if there is not something
that can be done at a local or regional level? Given the
widespread perception of less individual time and
practice income available for clinical research, is there
anything that our regional vascular society can do to
facilitate this type of scientific inquiry? I believe that
there is.
I would suggest that our Society should sponsor
multigroup, cooperative clinical research trials. Let
me explain this. I am not proposing another vascular
registry where every member of a society is asked to
contribute data concerning a specific procedure. Such
registries are inherently biased, notoriously difficult to
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maintain, and, with the exception of a publication
from this Society by Johnson and Squires,6 have large-
ly been unproductive of real scientific advancement.
Rather, I am proposing that our Society solicit volun-
tary participation in focused clinical trials that could
involve a few key university centers and a few key
practice groups. I see real value in regional coopera-
tive clinical research for several reasons. First, it could
rapidly increase the rate of acquisition of a sufficient
number of patients to answer some nagging questions
about uncommon vascular problems. Second, it could
stimulate collaboration among members in both uni-
versity centers and private practice and allow many of
us to find an outlet for our research motivations.
Perhaps most importantly, cooperative research could
leverage the small amount of time that each of us has
into a much more productive effort. Regional organi-
zation among vascular surgeons who know each other
well would more likely stimulate enthusiastic partici-
pation. A regional project would reduce travel costs
by investigators and study coordinators. Finally,
regional organization should simplify the infrastruc-
ture necessary to support such an endeavor, making
the entire project more feasible.
What would our Society actually contribute to
this effort? First, I would recommend the establish-
ment of a Clinical Trials Committee to receive and
review proposals for such studies from our members,
to select studies for sponsorship, to invite other
members to participate, and to monitor the imple-
mentation and performance of the resulting trials.
Second, I believe that we should provide funding for
a nurse research study coordinator, central data pro-
cessing, and statistical analysis for such projects. In a
time of relative financial difficulty for all of us, you
might well ask how such financial support would be
possible. I believe that a joint effort between our
membership and our corporate colleagues would
potentially allow us to fund these central research
support functions. As a charitable organization, our
members could contribute donations specifically to
this activity, as could corporate sponsors. Based on
our successful efforts this year to achieve corporate
support for our silver anniversary meeting, I believe
that such support would be forthcoming for clinical
research trials that would substantially advance our
understanding of vascular disease.
I am sure that the skeptics among you wonder
whether this could be possible. Traditionally, many of
our academic institutions have demonstrated more
open competition than professed partnerships. In
part, this is stimulated by a promotion and tenure
system that values first-authored publications and
devalues group effort. We must abandon the use of
this counterfeit currency in our academic enterprises
and begin to stimulate and value collaborative inter-
action. I am not suggesting that each clinical trial
does not need a leader or a first-author. However,
would it not be refreshing to have multi-center trials
conducted by a group of our members that would be
presented at this meeting and then published under
the sponsorship of the New England Society for
Vascular Surgery Clinical Trials Committee? I believe
it is also time for our university centers to recognize
the value and interest of non-university–affiliated vas-
cular surgeons in participating in such studies.
Research interest does not end with surgical residen-
cy. Many vascular surgeons who are not at university
centers would embrace the opportunity to participate
in focused research studies. 
Is there any precedence for this type of clinical
research activity sponsored by a vascular society? In
fact, there is. A good example is the abdominal aor-
tic aneurysm study sponsored by the Canadian
Society for Vascular Surgery, which is also meeting
today in Toronto.7,8 As most of you know, this activ-
ity was organized by Dr Wayne Johnston but was
possible because 72 members of the Canadian society
volunteered to submit data from their practices.
Because of the widespread nature of this study and
the diversity of practices, data forms were kept short
so that participating surgeons could easily complete
them. Initially, the study was limited to in-hospital
data, to avoid the complexities associated with
prospective data collection during long-term follow-
up. Later, a follow-up component was added, with
data retrieval facilitated by a small per-patient pay-
ment made directly to the secretary in each surgeon’s
office.9,10 This work led to five important publica-
tions in the Journal of Vascular Surgery, an outstand-
ing example of the potential benefit of cooperative
clinical research organized through a vascular soci-
ety.7-11 A key element in the success of this venture,
according to Dr Johnston, was the collegiality among
members of the society and their frequent contact,
which stimulated enthusiasm and participation.12
The Canadian Society for Vascular Surgery continues
to conduct cooperative clinical research, such as a
current project to develop patient-oriented outcomes
for quality control in vascular surgery.13
Another good example of cooperative clinical
research in vascular surgery is The Joint Vascular
Research Group organized 15 years ago by a group of
like-minded vascular surgeons from both university
and non-university hospitals throughout England.
According to Professor Peter Bell, this group decided
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that insufficient clinical trials were being conducted in
vascular surgery and agreed that by cooperating on
focused trials they could improve this with a relatively
small budget.14 These surgeons formed an informal
organization, meeting twice per year, and recruited
contributions from industry to support their research.
These funds were used to pay for a central research
coordinator; the local costs for data collection were
borne by each center or practice. The group receives
suggestions for projects from its members and deter-
mines which of these to put forward, with participa-
tion on a voluntary basis by interested members and
centers. This collaboration has led to a number of suc-
cessful randomized clinical trials, including a study of
Miller vein collars for PTFE grafts, a comparison of
below knee amputation flaps, and a trial evaluating
heparin in aneurysm surgery.4,15,16 These topics illus-
trate the value of straightforward, focused research
questions that can be answered with limited funding
by a group of friends working cooperatively. Among
the examples of such activity in other countries is an
initiative to sponsor clinical research recently launched
by the Royal Australasian College of Surgeons, which
is of considerable interest to the Fellows of their
Vascular Division according to Mr Sam Mellick.17
Based on these examples, a key concept for coop-
erative clinical research appears to be the selection of
straightforward questions with focused data forms
that can be easily handled by vascular surgeons in
their practice. Given the information technologies
currently available, electronic transfer of such data to
a central data analyst would require only that each
investigator have a computer and modem, a likely
scenario in most centers today. Monitoring data
accuracy through site visits and chart review would
be a responsibility of a nurse research study coordi-
nator, as occurs in any multicentered trial.
It is important that we do not succumb to the
widely held belief that successful clinical research,
especially multicenter trials, cannot be conducted
without multimillion dollar support from central
granting agencies. There are several examples, as
cited earlier, that belie this conclusion. Rather, we
must embrace the concept that coordinated, cooper-
ative efforts by a group of well-motivated surgeon-
scientists will likely be far more successful in gener-
ating productive clinical research during the next 25
years than the continued frustration of isolated indi-
vidual efforts in single institutions. I believe that the
same geographic proximity that gave our founders
optimism concerning the success of our Society are
equally applicable to regional cooperative clinical
research. In this regard, I think that we are much
better poised for success than our national societies,
if for no other reason than the collegiality of our
members at these informal meetings.
As much as I would like to take credit for the orig-
ination of these ideas, as usual, nothing is really new.
After generating these ideas, my research revealed that
not only had other people thought of these ideas but
they had also actually published them. Minutes of the
first organizational meeting of our Society, 25 years
ago this month, indicate that one goal was “to provide
third party payers with an authoritative group with
which to deal.” In a review of national and regional
vascular societies, Perry and Kempczinski18 point out
that variation in regional socioeconomic issues, not
well addressed at the national level, was a common
stimulus for organizing regional societies. Finally, in
his 1983 Presidential Address to the Southern
Association for Vascular Surgery, Dr Calvin Ernst spec-
ulated on the future role of regional societies and sug-
gested that sponsoring multi-institution research trials
and consulting with third-party payers concerning
reimbursement issues might be productive.19 Other
societies, such as the Canadian Society for Vascular
Surgery and the Joint Vascular Research Group, have
already been successful with cooperative clinical
research trials. Our national vascular societies and,
recently, other regional societies have implemented
continuing education courses in the emerging
endovascular techniques. Thus, although these ideas
are not new, I would point out that they have not been
widely implemented and certainly not by our Society.
In conclusion, I have been enormously proud to
serve as President of this Society, especially during
this 25th anniversary year. We bear witness to the
success and enduring benefit of our activities. I
believe, however, that there is room for improve-
ment, in the most positive sense of that term. I
would specifically recommend that we promote
interaction with regional third-party payers, that we
develop a program for continuing education of our
members in developing vascular technology, and
that we sponsor cooperative clinical research studies
by our members. As our founders did in 1973, we
should develop a template for regional vascular soci-
eties for the next 25 years. Let us expand our hori-
zons and think of what could be. I certainly look for-
ward to the stimulation that this Society and its next
25 presidents will provide. I know that it will count
as much after 50 years as it does to us today. 
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